FDA
label_change
· 2023-12-28
FDA Approved: NEBIVOLOL — Supplemental Application (Camber Pharmaceuticals, Inc.)
Summary
The FDA lists a Camber Pharmaceuticals supplemental application for Nebivolol, indicating a label update under the ANDA for Nebivolol.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NEBIVOLOL (NEBIVOLOL)